Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

Several immunomodulatory checkpoint inhibitors have been approved for the treatment of patients with advanced melanoma, including ipilimumab, nivolumab and pembrolizumab. Talimogene laherparepvec is the first oncolytic virus to gain regulatory approval in the USA; it is also approved in Europe. Tali...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeller, Christoph, Michielin, Olivier, Ascierto, Paolo A., Szabo, Zsolt, Blank, Christian U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995227/
https://www.ncbi.nlm.nih.gov/pubmed/27372293
http://dx.doi.org/10.1007/s00262-016-1860-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995227/
https://www.ncbi.nlm.nih.gov/pubmed/27372293
http://dx.doi.org/10.1007/s00262-016-1860-3

Ejemplares similares